From the Sections of Infectious Diseases and Global Health.
Emergency Medicine, University of Chicago, Chicago, IL.
Sex Transm Dis. 2024 Nov 1;51(11):728-733. doi: 10.1097/OLQ.0000000000001999. Epub 2024 Jun 11.
Current guidelines recommend concurrent screening for HIV and syphilis with gonorrhea and chlamydia testing. Despite this, many patients are still not screened. This study describes trends in demographics and encounter locations associated with missed opportunities for HIV and syphilis screening among patients tested for gonorrhea or chlamydia.
This is a retrospective review of all encounters with gonorrhea or chlamydia testing in a large, urban hospital from November 1, 2018, to July 31, 2021. Demographic information and encounter location were extracted from the medical record. Encounters were categorized as including both HIV and syphilis (complete) screening, HIV screening only, or neither. Logistic regression was used to examine associations between demographics and encounter location and likelihood of complete screening.
There were 42,791 patient encounters, of which 40.2% had complete screening, 6.2% had concurrent HIV screening only, and 53.6% had no concurrent screening. Increasing age, female sex (adjusted odds ratio [aOR], 0.58; 95% confidence interval [CI], 0.55-0.61; P < 0.01), non-Hispanic Black race (aOR, 0.52; 95% CI, 0.49-0.55; P < 0.01), and public insurance (aOR, 0.72; 95% CI, 0.69-0.75; P < 0.01) were associated with lower odds of complete screening. Emergency department (ED) encounters were most likely to include complete screening (aOR, 3.11; 95% CI, 2.96-3.26; P < 0.01).
This study found that a large proportion of patients tested for gonorrhea and chlamydia had missed opportunities for HIV and syphilis screening. Significant demographic disparities were found. The emergency department was most likely to screen for both HIV and syphilis. Decreasing disparities in screening could have profound effects on the HIV and syphilis epidemics.
目前的指南建议同时筛查淋病奈瑟菌、沙眼衣原体、梅毒和 HIV。尽管如此,仍有许多患者未接受筛查。本研究描述了在对淋病奈瑟菌或沙眼衣原体进行检测的患者中,与 HIV 和梅毒筛查机会错失相关的人口统计学特征和就诊地点的趋势。
这是对一家大型城市医院 2018 年 11 月 1 日至 2021 年 7 月 31 日所有淋病奈瑟菌或沙眼衣原体检测就诊的回顾性研究。从病历中提取人口统计学信息和就诊地点。就诊被分为包括 HIV 和梅毒(完全)筛查、仅 HIV 筛查或均未进行筛查。使用逻辑回归分析人口统计学特征和就诊地点与完全筛查的可能性之间的关联。
共 42791 例患者就诊,其中 40.2%接受了完全筛查,6.2%同时接受了 HIV 筛查,53.6%未进行任何 HIV 筛查。年龄较大(调整后的优势比 [aOR],0.58;95%置信区间 [CI],0.55-0.61;P < 0.01)、女性(aOR,0.58;95% CI,0.55-0.61;P < 0.01)、非西班牙裔黑人种族(aOR,0.52;95% CI,0.49-0.55;P < 0.01)和公共保险(aOR,0.72;95% CI,0.69-0.75;P < 0.01)与完全筛查的可能性较低相关。急诊科就诊最有可能进行完全筛查(aOR,3.11;95% CI,2.96-3.26;P < 0.01)。
本研究发现,很大一部分接受淋病奈瑟菌和沙眼衣原体检测的患者错过了 HIV 和梅毒筛查的机会。发现了显著的人口统计学差异。急诊科最有可能同时筛查 HIV 和梅毒。减少筛查中的差异可能对 HIV 和梅毒流行产生深远影响。